AtriCure Insider Buy‑After‑Vest Surge Signals Executive Confidence Amid Strong Earnings
Insider buying at AtriCure signals confidence in its cardiac device strategy, as execs purchase 250k+ shares after Q4 earnings beat expectations.
4 minutes to read